|
Exploration and evaluation of putative lead compounds and drug targets is a data- and hypothesis-driven process.
Informed decision making requires researchers to connect information from a wide range of proprietary and public technologies ("-omics") used to shed light on disease mechanisms.
Biomax provides a highly flexible and intuitive system which allows scientists to identify novel relationships and patterns in biomedical information networks.
Quick turnaround time in a dynamic research environment is ensured by configuring the solution to your specific requirements. This approach avoids cost-intensive development cycles, providing a high return on investment.
BioXM and BioRS systems provide an integrated solution for data analysis, data and knowledge management, knowledge generation and hypothesis modeling for a broad range of drug discovery requirements.
The BioLT tool was used to build a knowledge base with human genetic and cancer gene information, which provides the content with which to build your knowledge.
Contact Biomax
| 
